-
Ozempic Eye Problems Side Effect Warnings Not In US Drug Label
Ozempic NAION Risk Is Highlighted In Other Countries, So Why Not Here? (Posted by Tom Lamb at Drug Injury Watch) The current Prescribing Information document for Ozempic (Revised: 5/2026 version) in the US does not include any…
-
Semaglutide-associated Vision Loss Due to NAION – New Medical Report, May 2026
Ozempic, Wegovy, and Rybelsus Are Semaglutide Drugs Linked to Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) (Posted by Tom Lamb at Drug Injury Watch) Before we direct you to a new medical report about semaglutide-associated vision loss due…
-
Ozempic And Other GLP-1RA Use Associated With NAION Eye Side Effect
New 2026 Medical Article Published By JAMA Network Open Investigates Drug Safety Issue (Posted by Tom Lamb at Drug Injury Watch) An increasingly known but still-developing drug safety issue is that of Ozempic and other GLP-1RA use…
-
Tavneos Warnings For VBDS Liver Side Effect Increased In April 2026
Tavneos Drug Label Change By Amgen Just 2 Days After Tavneos Drug Recall Statement By FDA (Posted by Tom Lamb at Drug Injury Watch) The Tavneos drug safety issue has an interesting new development. On April 29,…
-
Tavneos Liver Injury Drug Safety Communication Issued by FDA in Late March 2026
Just 2 Months Earlier, Amgen Refused an FDA Request to Withdraw Tavneos; Will There Be a Tavneos Recall Soon? (Posted by Tom Lamb at Drug Injury Watch) On March 31, 2026, the FDA issued a Tavneos liver…
